Neuraltus ALS drug wins fast track, orphan status - San Francisco Business Times**** "An experimental treatment for Lou Gehrig’s disease won fast track and orphan drug designations from the Food and Drug Administration, potentially speeding ..."#Emergency#Registration & Regulation·bizjournals.com·Aug 27, 2021Neuraltus ALS drug wins fast track, orphan status - San Francisco Business Times
